Bayer seeks FDA approval for improved second-generation hemophilia A product June 12, 1998 No Comments
Targeted NO donor enhances the activity of aspirin and heparin in preventing embolization June 8, 1998 No Comments
P2T purinoceptor receptor antagonists with platelet antiaggregatory activity May 28, 1998 No Comments
RSS